Neogen Corp (NEOG)
8.15 x 1 8.65 x 35
Pre-market by (Cboe BZX)
8.64 -0.32 (-3.57%) 03/28/25 [NASDAQ]
8.15 x 1 8.65 x 35
Pre-market 8.64 unch (unch) 16:00 ET
for Fri, Mar 28th, 2025
Results
download Want to compare other data? Select FieldsSymbol | NEOG | ABT | BSX | SYK | MDT |
Company | Neogen Corp | Abbott Laboratories | Boston Scientific Corp | Stryker Corp | Medtronic Inc |
Price Information | |||||
Exchange | NASDAQ | NYSE | NYSE | NYSE | NYSE |
Open | 8.94 | 131.26 | 99.94 | 365.51 | 87.85 |
High | 9.09 | 133.46 | 100.42 | 368.51 | 88.38 |
Low | 8.55 | 130.75 | 98.02 | 363.27 | 87.23 |
Last | 8.64 | 130.82 | 99.36 | 364.50 | 87.63 |
Change | -0.32 | -0.53 | -1.44 | -3.04 | -1.35 |
% Change | -3.57% | -0.40% | -1.43% | -0.83% | -1.52% |
Volume | 2,452,200 | 6,708,500 | 7,404,000 | 1,274,300 | 6,320,300 |
20-Day Average Volume | 4,503,690 | 7,507,750 | 8,157,870 | 1,544,350 | 8,342,600 |
Previous Close | 8.96 | 131.35 | 100.80 | 367.54 | 88.98 |
Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 9.28 | 131.04 | 100.05 | 374.71 | 91.78 |
20-Day Raw Stochastic | 14.10% | 37.78% | 49.43% | 11.87% | 4.43% |
20-Day Relative Strength | 36.50% | 52.98% | 47.76% | 40.55% | 42.27% |
Weighted Alpha | -48.66 | +21.66 | +42.33 | +3.13 | +3.76 |
Today's Opinion | 100% Sell | 72% Buy | 40% Buy | 8% Sell | 40% Buy |
Previous Opinion | 100% Sell | 72% Buy | 56% Buy | 8% Sell | 56% Buy |
Last Month's Opinion | 100% Sell | 100% Buy | 80% Buy | 88% Buy | 64% Buy |
Performance | |||||
5-Days | |||||
%Chg | -2.37% since 03/21/25 | +3.55% since 03/21/25 | -1.32% since 03/21/25 | -1.78% since 03/21/25 | -2.99% since 03/21/25 |
Low | 8.31 on 03/26/25 | 124.50 on 03/25/25 | 98.02 on 03/28/25 | 359.99 on 03/26/25 | 87.23 on 03/28/25 |
High | 9.12 on 03/24/25 | 133.46 on 03/28/25 | 104.35 on 03/25/25 | 379.04 on 03/25/25 | 90.84 on 03/24/25 |
1-Month | |||||
%Chg | -14.03% since 02/28/25 | -5.21% since 02/28/25 | -4.27% since 02/28/25 | -5.62% since 02/28/25 | -4.77% since 02/28/25 |
Low | 8.31 on 03/26/25 | 124.50 on 03/25/25 | 93.29 on 03/10/25 | 359.99 on 03/26/25 | 87.23 on 03/28/25 |
High | 10.65 on 03/10/25 | 141.23 on 03/04/25 | 105.57 on 03/03/25 | 398.00 on 03/05/25 | 96.25 on 03/10/25 |
3-Month | |||||
%Chg | -30.49% since 12/27/24 | +13.77% since 12/27/24 | +9.60% since 12/27/24 | -0.71% since 12/27/24 | +8.53% since 12/27/24 |
Low | 8.31 on 03/26/25 | 110.86 on 01/15/25 | 88.81 on 01/02/25 | 351.85 on 01/07/25 | 79.29 on 12/30/24 |
High | 13.40 on 01/07/25 | 141.23 on 03/04/25 | 107.17 on 02/05/25 | 406.19 on 01/28/25 | 96.25 on 03/10/25 |
6-Month | |||||
%Chg | -47.98% since 09/27/24 | +16.36% since 09/27/24 | +19.21% since 09/27/24 | +1.17% since 09/27/24 | -1.89% since 09/27/24 |
Low | 8.31 on 03/26/25 | 110.86 on 01/15/25 | 80.64 on 10/30/24 | 343.95 on 10/07/24 | 79.29 on 12/30/24 |
High | 17.18 on 09/30/24 | 141.23 on 03/04/25 | 107.17 on 02/05/25 | 406.19 on 01/28/25 | 96.25 on 03/10/25 |
Key Statistics | |||||
Market Capitalization, $K | 1,874,396 | 226,884,144 | 146,960,384 | 139,125,632 | 112,389,240 |
Shares Outstanding, K | 216,944 | 1,734,323 | 1,479,070 | 381,689 | 1,282,543 |
Annual Sales | 924,220,000 | 41,950,000,000 | 16,747,000,000 | 22,595,000,000 | 32,364,000,000 |
Annual Net Income | -9,420,000 | 13,402,000,000 | 1,854,000,000 | 2,993,000,000 | 3,677,000,000 |
Last Quarter Sales | 231,260,000 | 10,974,000,000 | 4,562,000,000 | 6,436,000,000 | 8,292,000,000 |
Last Quarter Net Income | -456,280,000 | 9,229,000,000 | 568,000,000 | 546,000,000 | 1,294,000,000 |
60-Month Beta | 1.27 | 0.70 | 0.77 | 0.95 | 0.80 |
Per-Share Information | |||||
Most Recent Earnings | 0.11 on 01/10/25 | 1.34 on 01/22/25 | 0.70 on 02/05/25 | 4.01 on 01/28/25 | 1.39 on 02/18/25 |
Latest Earnings Date | 04/09/25 | 04/16/25 | 04/23/25 | 04/29/25 | 05/21/25 |
Most Recent Dividend | N/A | 0.590 on 01/15/25 | N/A | 0.840 on 12/31/24 | 0.700 on 03/28/25 |
Next Ex-Dividends Date | N/A | 04/15/25 | N/A | 12/31/24 | 03/28/25 |
Ratios | |||||
Price/Earnings ttm | 22.40 | 28.13 | 40.16 | 30.15 | 16.66 |